Effects of Intravenous Pamidronate Therapy on Paget’s Disease of Bone
- 1 October 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 308 (4) , 226-233
- https://doi.org/10.1097/00000441-199430840-00003
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Treatment of Paget's disease of bone with single dose intravenous pamidronate.Annals of the Rheumatic Diseases, 1993
- TREATMENT OF PAGET'S DISEASE BY WEEKLY INFUSIONS OF 3-AMINOHYDROXYPROPYLIDENE-1, 1-BISPHOSPHONATE (APD)Rheumatology, 1992
- Clinical experience with pamidronate in the treatment of Paget's disease of bone.Annals of the Rheumatic Diseases, 1991
- Treatment of paget's disease with intermittent low-dose infusions of disodium pamidronate (APD)Journal of Bone and Mineral Research, 1990
- SIDE-EFFECTS OF PAMIDRONATEThe Lancet, 1989
- Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).BMJ, 1987
- Intravenous aminopropylidene bisphosphonate (APD) in the treatment of paget's bone diseaseJournal of Bone and Mineral Research, 1987
- Efficacious Management with Aminobisphosphonate (APD) in Paget??s Disease of BoneClinical Orthopaedics and Related Research, 1987
- Paget's disease of bone treated in five days with AHPrBP (APD) per OsJournal of Bone and Mineral Research, 1987
- Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.Annals of the Rheumatic Diseases, 1986